Comparison

Vimseltinib European Partner

Item no. M11516-5mg
Manufacturer AbMole
CASRN 1628606-05-2
Amount 5mg
Category
Type Inhibitors
Specific against other
Purity >99%
Formula C23H25N7O2
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias DCC-3014
Available
Target Information
CSF-1R (c-Fms)
Molecular Weight
431, 49
Solubility
DMSO ≥ 60 mg/mL
Bioactivity information
Vimseltinib (DCC-3014) is a highly selective, orally active inhibitor of colony-stimulating factor-1 receptor (CSF-IR) and c-Kit with IC50 values of <0.01 μM and 0.1-1 μM, respectively.Vimseltinib is used in studies related to tenosynovial giant cell tumors (TGCT).

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close